Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

AmbiJet-assisted treatment for inflamed dental implants

Official title: Randomized, Controlled, Exploratory Study on the Treatment of Dental Implants Using the AmbiJet System for Peri-implantitis and Peri-implant Mucositis (AmbiJet-FIH)

Run by Freiburger Medizintechnik GmbH · NCT07722715 · Data updated 2026-11-12

This study tests whether applying cold atmospheric plasma with the AmbiJet system after standard cleaning helps reduce inflammation around dental implants more quickly in adults with peri-implant mucositis or peri-implantitis.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment26 (estimated)
SponsorFreiburger Medizintechnik GmbH
Industry-sponsored
Locations1 site (Romny)
StatusRecruiting
StartedFebruary 14, 2026
Main results expectedNovember 2026
Study endsNovember 20, 2026
Registry record updatedJuly 24, 2026
Trial IDNCT07722715 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with one to five implants showing peri-implant mucositis or peri-implantitis who have acceptable oral hygiene and meet the dental criteria.

Probably not a fit

Patients without inflammatory signs, with contraindicated materials, or with uncontrolled systemic conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients with inflammation around dental implants receive conventional mechanical cleaning, plus an additional treatment with the AmbiJet cold plasma system to see if it safely accelerates resolution of inflammation. The trial will assess safety, tolerability, and clinical signs of inflammation after treatment. Participants are adults aged 18 to 65 with one to five implants showing mucositis or peri-implantitis, and follow-up considerations follow standard guidelines. The study is conducted under the Freiburger Medizintechnik sponsorship at a single research site.

Why it matters

Potential benefit: If successful, patients could experience faster reduction of gum inflammation around implants and potentially better implant survival.

How similar studies have gone: Prior data indicate peri-implant inflammation is common, but this specific CAP approach is novel and its effectiveness requires confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

General criteria:

* Men or women aged \>= 18 and \<= 65 years.
* For women of childbearing age: a form of contraception recognized by conventional medicine during the study.
* Written consent has been obtained from each patient for the study.

Dental criteria:

* Current X-ray of the implant region available (\<= 6 months prior to first treatment).
* One to five implants with bone loss from the start of the part of the implant intended for osseointegration (X-ray findings).
* Bleeding and/or suppuration after or without probing at the implant in question (peri-implant mucositis/peri-implantitis).
* Clinical signs of inflammation (swelling, redness, soft tissue) on the implant in question (peri-implant mucositis/peri-implantitis).
* Average oral hygiene (i.e., brushing teeth at least twice a day).

Exclusion Criteria:

General criteria:

* Known allergies to materials used in the study (gold, copper, polyimide).
* Diabetes (type I or type II), vasculitis, osteoporosis, osteomalacia.
* Smokers (\>1 cigarette/week).
* Use of medications to modulate bone metabolism (e.g., bisphosphonates).
* Eating disorders such as bulimia or anorexia nervosa.
* Use of antibiotics within the last 2 months prior to the start of the study.
* Application of local antibiotics in the oral cavity within the last 2 months prior to the start of the study.
* Use of antimicrobial mouthwashes within the last month before the start of the study.
* Anti-inflammatory medication within the last month before the start of the study.
* Pregnancy or breastfeeding.
* Alcoholism or drug abuse.
* Wound healing disorders.
* Immunosuppression.
* Condition following insertion of an electrical, electrically active, or electronic implant.

Dental criteria:

* An implant with bone loss \>6 mm from the start of the part of the implant intended for osseointegration (X-ray findings) (peri-implantitis).
* Pathological changes in the oral mucosa or gingiva, such as oral lichen planus, chronic recurrent aphthae, melanotic macula, precancerous lesions (e.g., leukoplakia), melanomas.
* Use of medically unacceptable types of treatment, therapies, or substances (off-label use of treatments for peri-implant mucositis or peri-implantitis).

Where it's running

  • LLC "Institute of Implantological Research
    Romny, Ukraine
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.